Quarterly report pursuant to Section 13 or 15(d)

Revenues from Contracts and Significant Customers (Narrative) (Details)

v3.21.2
Revenues from Contracts and Significant Customers (Narrative) (Details)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
product
Sep. 30, 2020
USD ($)
Dec. 31, 2020
customer
Disaggregation of Revenue [Line Items]          
Number of marketed products | product     7    
Revenue from Contract with Customer, Including Assessed Tax | $ $ 19,610 $ 9,447 $ 45,617 $ 30,808  
Dermatology Products Sales [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]          
Disaggregation of Revenue [Line Items]          
Number of customers | customer         1
Dermatology Products Sales [Member] | One Customer [Member] | Customer Concentration Risk [Member] | Revenue [Member]          
Disaggregation of Revenue [Line Items]          
Concentration risk, percentage 10.10%        
Dermatology Products Sales [Member] | Customer one [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]          
Disaggregation of Revenue [Line Items]          
Concentration risk, percentage     20.70%   14.50%
Dermatology Products Sales [Member] | Customer Two [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]          
Disaggregation of Revenue [Line Items]          
Concentration risk, percentage     14.90%